Choice of antibiotics in pregnant women with UTI
Reading File
Finding Sources
Finding Sources
Searching PubMed
pregnancy urinary tract infection antibiotics
Searching the Web
ACOG Clinical Consensus urinary tract infections pregnant individuals antibiotic regimens nitrofurantoin cephalexin
Finding Sources
Finding Sources
Reading Web Page
https://www.acog.org/clinical/guidance/clinical-consensus/20…
For asymptomatic bacteriuria or acute cystitis in pregnancy, obtain a urine culture and treat according to susceptibility. Typical oral choices are:
| Antibiotic | Common regimen | Key points |
|---|---|---|
| Nitrofurantoin | 100 mg orally twice daily for 5-7 days | Good first-line lower-UTI option. Avoid in G6PD deficiency. Do not use for pyelonephritis because kidney-tissue levels are inadequate. |
| Cephalexin | 250-500 mg orally every 6 hours for 5-7 days | Common, generally well tolerated choice. |
| Amoxicillin-clavulanate | 500/125 mg every 8 hours or 875/125 mg every 12 hours for 5-7 days | Use when culture supports susceptibility. |
| Fosfomycin trometamol | 3 g orally once | An option for uncomplicated lower UTI only, not pyelonephritis. |
| Trimethoprim-sulfamethoxazole | 160/800 mg orally twice daily for 5-7 days | Reserve for situations where preferred options are unsuitable and culture supports it. Avoid if possible in the first trimester because trimethoprim is a folate antagonist, and avoid near term because of neonatal bilirubin concerns. |
Avoid empiric ampicillin or amoxicillin alone for cystitis in pregnancy because E. coli resistance is common. They can still be used if the urine culture confirms susceptibility. ACOG recommends a targeted 5-7-day course for asymptomatic bacteriuria and acute cystitis, with culture-guided adjustment when available (ACOG UTI consensus).
If pyelonephritis is suspected
Fever of 38°C or higher, flank pain/CVA tenderness, chills, vomiting, or systemic illness in a pregnant patient suggests pyelonephritis. This usually requires hospital assessment and IV antibiotics, for example ceftriaxone, cefepime, or ampicillin plus gentamicin, then step-down to a culture-directed oral drug after improvement. Complete 14 days total therapy. Nitrofurantoin and fosfomycin should not be used for pyelonephritis.
Recurrent UTI
After recurrent infection or a pyelonephritis episode, suppressive therapy may be considered for the rest of pregnancy, commonly:
- Nitrofurantoin 50-100 mg at bedtime, or
- Cephalexin 250-500 mg at bedtime,
chosen based on culture susceptibility.
The exact antibiotic should account for gestational age, allergy history, prior cultures, renal function, local resistance, and whether illness is limited to the bladder or involves the kidneys.
Find the latest guidelines for UTI treatment in pregnancy
Reading File
Reading File
Searching the Web
site:acog.org urinary tract infections pregnant individuals Clinical Consensus 2023 reaffirmed 2026 recommendations treatment
Searching the Web
site:nice.org.uk urinary tract infection lower pregnancy antimicrobial prescribing guideline 2025
Searching the Web
pregnancy UTI treatment guideline 2025 2026 asymptomatic bacteriuria pyelonephritis guideline
Searching PubMed
pregnancy urinary tract infection treatment
Searching PubMed
pregnancy urinary tract infection antibiotics
Finding Sources
Reading Web Page
https://www.nice.org.uk/guidance/ng109/chapter/recommendatio…
Reading Article
PMID: 37473414
Reading Web Page
https://www.nice.org.uk/guidance/ng111/chapter/Recommendatio…
Latest guidance for UTI treatment in pregnancy
The most directly applicable current obstetric guidance is the ACOG Clinical Consensus, 2023, reaffirmed in 2026, on UTIs in pregnant individuals. The UK NICE lower-UTI guideline remains current and provides explicit regimen examples. These should be adapted to the urine culture, allergies, renal function, prior resistant organisms, and local resistance data.
1. Screening and asymptomatic bacteriuria (ASB)
- Obtain one urine culture early in prenatal care.
- Treat ASB when the culture shows 100,000 CFU/mL or more of a uropathogen, even without symptoms.
- Use a culture-directed 5-7 day course according to ACOG. IDSA suggests 4-7 days, using the shortest effective regimen for the selected agent (IDSA ASB guideline).
- Evidence is insufficient to require routine repeat cultures after a negative initial screen or after treatment, though a follow-up culture may be considered clinically.
2. Acute cystitis
Obtain a urine culture before or at the time treatment begins. Treat with 5-7 days of a targeted antibiotic.
Usual pregnancy-compatible oral options
| Drug | Example regimen | Important limitation |
|---|---|---|
| Nitrofurantoin | 100 mg orally twice daily for 5-7 days | Use only for lower UTI. Avoid in G6PD deficiency and generally avoid at term. NICE specifies 7 days and eGFR 45 mL/min or more. |
| Cephalexin | 500 mg orally twice daily for 7 days | Adjust to culture and local susceptibility. |
| Amoxicillin-clavulanate | Culture-guided regimen for 5-7 days | Reasonable if susceptible. |
| Amoxicillin | Culture-guided only | Do not use empirically because E. coli resistance is common. NICE example: 500 mg three times daily for 7 days. |
| Fosfomycin trometamol | 3 g orally once | Option for lower UTI only; do not use when pyelonephritis is possible. |
Avoid empiric amoxicillin or ampicillin in pregnancy because of high E. coli resistance. ACOG considers nitrofurantoin and sulfonamides acceptable options when clinically appropriate, including in the first trimester if no suitable alternatives exist, although treatment should be individualized.
3. Acute pyelonephritis
Suspect this with fever 38°C or higher plus flank pain/CVA tenderness, often with nausea, vomiting, rigors, or systemic illness.
- Initial inpatient management is recommended in pregnancy.
- Send urine culture, start an IV antibiotic that penetrates renal tissue, and tailor therapy once susceptibilities return.
- Continue IV treatment until clear clinical improvement, then switch to an effective oral agent.
- ACOG recommends 14 days total antibiotic therapy for pregnancy-associated pyelonephritis.
- Do not use nitrofurantoin or oral fosfomycin for pyelonephritis because they do not achieve adequate renal parenchymal concentrations.
NICE lists cefalexin as an oral option for acute pyelonephritis and recommends IV cefuroxime if severely unwell or unable to take oral drugs, with culture-guided changes (NICE pyelonephritis guidance). In the US, hospital empiric choices commonly include a parenteral cephalosporin such as ceftriaxone, then adjustment to culture results.
4. Recurrent UTI or after pyelonephritis
After recurrent UTI, or after an episode of pyelonephritis, ACOG says clinicians may consider suppressive prophylaxis for the remainder of pregnancy, using an agent to which the isolate is susceptible, for example:
- Nitrofurantoin 100 mg orally nightly, or
- Cephalexin 250-500 mg orally nightly.
Practical safety points
- Nitrofurantoin: lower UTI only; avoid with G6PD deficiency and near term because of concern for neonatal hemolysis.
- Trimethoprim-sulfamethoxazole: avoid when feasible in the first trimester because of folate antagonism and avoid late in pregnancy when alternatives are available. If needed early in pregnancy, ensure appropriate folate supplementation and specialist prescribing judgment.
- Fluoroquinolones: generally avoided in pregnancy unless there is no appropriate alternative and expert advice supports use.
- Tetracyclines: avoid in pregnancy.
The newer IDSA 2025 complicated-UTI guideline supports culture-directed therapy and early narrowing of broad treatment, but it is not a substitute for pregnancy-specific ACOG guidance. Its shorter-duration recommendations for general complicated UTI should not automatically replace ACOG's 14-day recommendation for pyelonephritis in pregnancy.
Urgent assessment is needed for fever, flank pain, vomiting, contractions, reduced fetal movements, hypotension, or inability to retain oral antibiotics.
This is a shared conversation. Sign in to Orris to start your own chat.